Differential regulation of interleukin (IL)-4, IL-5, and IL-10 during measles in Zambian children

Journal of Infectious Diseases

Volumn 186, Issue 7, 2002, Pages 879-887

  Moss, William J ^a   Ryon, Judith J ^a   Monze, Mwaka ^b   Griffin, Diane E ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY TEACHING HOSPITAL   (Zambia)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5;

ARTICLE; CHILD; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; IMMUNOREACTIVITY; INFECTION RESISTANCE; MAJOR CLINICAL STUDY; MALE; MEASLES; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; ZAMBIA;

CHILD; CHILD, PRESCHOOL; COHORT STUDIES; EOSINOPHILS; FEMALE; HUMANS; IMMUNOGLOBULIN E; INFANT; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKIN-5; LEUKOCYTE COUNT; MALE; MEASLES; T-LYMPHOCYTE SUBSETS; ZAMBIA;

EID: 0036786349     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/344230     Document Type: Article

References (97)

1. Centers for Disease Control and Prevention. Global measles control and regional elimination, 1998-1999. MMWR Morb Mortal Wkly Rep 1999; 48:1124-30.
2. Morley D. Severe measles in the tropics. Br Med J 1969;1:297-300.
3. Whittle HC, Dossetor J, Oduloju A, Bryceson ADM, Greenwood BM. Cell-mediated immunity during natural measles infection. J Clin Invest 1978;62:678-84.
4. Akramuzzaman SM, Cutts FT, Wheeler JG, Hossain MJ. Increased childhood morbidity after measles is short-term in urban Bangladesh. Am J Epidemiol 2000;151:723-35.
5. Tamashiro VG, Perez HH, Griffin DE. Prospective study of the magnitude and duration of changes in tuberculin reactivity during uncomplicated and complicated measles. Pediatr Infect Dis J 1987;6:451-4.
6. Johnson RT, Griffin DE, Hirsch RL, et al. Measles encephalomyelitis-clinical and immunologic studies. N Engl J Med 1984;310:137-41.
7. Hirsch RL, Griffin DE, Johnson RT, et al. Cellular immune responses during complicated and uncomplicated measles virus infections of man. Clin Immunol Immunopathol 1984;31:1-12.
8. Ward BJ, Johnson RT, Vaisberg A, Jauregui E, Griffin DE. Cytokine production in vitro and the lymphoproliferative defect of natural measles virus infection. Clin Immunol Immunopathol 1991;61:236-48.
9. Heinzel FP, Sadick MD, Holaday BJ, Coffman RL, Locksley RM. Reciprocal expression of interferon gamma or interleukin-4 during the resolution or progression of murine leishmaniasis: evidence for expansion of distinct helper T cell subsets. J Exp Med 1989; 169:59-72.
10. Moench TR, Griffin DE, Obriecht CR, Vaisberg AJ, Johnson RT. Acute measles in patients with and without neurological involvement: distribution of measles virus antigen and RNA. J Infect Dis 1988;158:433-42.
11. Esolen LM, Ward BJ, Moench TR, Griffin DE. Infection of monocytes during measles. J Infect Dis 1993;168:47-52.
12. Karp CL, Wysocka M, Wahl LM, et al. Mechanism of suppression of cell-mediated immunity by measles virus. Science 1996;273:228-31.
13. Fugier-Vivier I, Servet-Delprat C, Rivailler P, Rissoan MC, Liu YJL, Rabourdin-Combe C. Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells. J Exp Med 1997;186:813-23.
14. Ward BJ, Johnson RT, Vaisberg A, Jauregui E, Griffin DE. Spontaneous proliferation of peripheral mononuclear cells in natural measles virus infection: identification of dividing cells and correlation with mitogen responsiveness. Clin Immunol Immunopathol 1990;55:315-26.
15. - class 1 MHC-restricted cytotoxic T lymphocytes (CTL) in recovery from measles. J Immunol 1990;144:2394-9.
16. Jaye A, Magnusen AF, Whittle HC. Human leukocyte antigen class I- and class II-restricted cytotoxic T lymphocyte responses to measles antigens in immune adults. J Infect Dis 1998; 177:1282-9.
17. Polack FP, Auwaerter PG, Lee SH, et al. Production of atypical measles in rhesus macaques: evidence for disease mediated by immune complex formation and eosinophils in the presence of fusion-inhibiting antibody. Nat Med 1999;5:629-34.
18. Griffin DE, Ward BJ. Jauregui E, Johnson RT, Vaisberg A. Immune activation during measles: interferon-γ and neopterin in plasma and cerebrospinal fluid in complicated and uncomplicated disease. J Infect Dis 1990;161:449-53.
19. Griffin DE, Ward BJ, Esolen LM. Pathogenesis of measles virus infection: an hypothesis for altered immune responses. J Infect Dis 1994:170(Suppl 1):S24-31.
20. Loots GG, Locksley RM, Blankespoor CM, et al. Identification of a coordinate regulator of interleukins 4, 13, and 5 by cross-species sequence comparisons. Science 2000;288:136-40.
21. Griffin DE, Ward BJ. Differential CD4 T cell activation in measles. J Infect Dis 1993;168:275-81.
22. Romagnani S. T-cell subsets (Th1 versus Th2). Ann Allergy Asthma Immunol 2000;85:9-18.
23. Bacharier LB, Geha RS. Molecular mechanisms of IgE regulation. J Allergy Clin Immunol 2000;105:S547-58.
24. Roboz GJ, Rafii S. Interleukin-5 and the regulation of eosinophil production. Curr Opin Hematol 1999;6:164-8.
25. Mochizuki M, Bartels J, Mallet AI, Christophers E, Schoder JM. IL-4 induces eotaxin: A possible mechanism of selective eosinophil recruitment in helminth infection and atopy. J Immunol 1998;160:60-8.
26. Fiorentino DF, Bond MW. Mosmann TR. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989;170:2081-95.
27. Becherel PA, LeGoff L, Frances C, et al. Induction of IL-10 synthesis by human keratinocytes through CD23 ligation: a cyclic adenosine 3′,5′-monophosphate-dependent mechanism. J Immunol 1997;159:5761-5.
28. Wanidworanun C, Strober W. Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis. J Immunol 1993;151:6853-61.
29. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209-20.
30. Mehrotra PT, Donnelly RP, Wong S, et al. Production of IL-10 by human natural killer cells stimulated with IL-2 and/or IL-12. J Immunol 1998;160:2637-44.
31. + T cell clones and peripheral blood T cells. J Immunol 1992;149:2378-84.
32. Rousset F, Garcia E, Defrance T, et al. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci USA 1992;89:1890-3.
33. Sieling PA, Abrams JS, Yamamura M, et al. Immunosuppressive roles for IL-10 and IL-4 in human infection. J Immunol 1993; 150:5501-10.
34. - T-cell subsets. Proc Natl Acad Sci USA 1994;91:18-22.
35. Hunter CA, Ellis-Neyes LA, Slifer T, et al. IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. J Immunol 1997;158:3311-6.
36. Shtrichman R, Samuel CE. The role of gamma interferon in antimicrobial immunity. Curr Opin Microbiol 2001;4:251-9.
37. Griffin DE, Ward BJ, Jauregui E, Johnson RT, Vaisberg A. Immune activation in measles. N Engl J Med 1989;320:1667-72.
38. + T cells following acute viral infection. Apoptosis 2000;5:431-4.
39. Zurawski SM, Chomarat P, Djossou O, et al. The primary binding subunit of the human interleukin-4 receptor is also a component of the interleukin-13 receptor. J Biol Chem 1995;270:13869-78.
40. de Waal Malefyt R, Figdor CG, Huijbens R, et al. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes: comparison with IL-4 and modulation by IFN-gamma or IL-10. J Immunol 1993;151:6370-81.
41. Wills-Karp M. IL-12/IL-13 axis in allergic asthma. J Allergy Clin Immunol 2001;107:9-18.
42. Griffin DE, Cooper SJ, Hirsch RL, et al. Changes in plasma IgE levels during complicated and uncomplicated measles virus infections. J Allergy Clin Immunol 1985;76:206-13.
43. Imani F, Proud D, Griffin DE. Measles virus infection synergizes with IL-4 in IgE class switching. J Immunol 1999; 162:1597-602.
44. Sewell WA, Mu HH. Dissociation of production of interleukin-4 and interleukin-5. Immunol Cell Biol 1996;74:274-7.
45. - T cells. J Clin Invest 1996;97:309-15.
46. Zang DH, Yang L, Ray A. Differential responsiveness of the IL-5 and IL-4 genes to transcription factor GATA-3. J Immunol 1998; 161:3817-21.
47. Cortegano I, del Pozo V, Cardaba B, et al. Galectin-3 regulates IL-5 gene expression on different cell types. J Immunol 1998;161:385-9.
48. Mori A, Kaminuma O, Miyazawa K, Ogawa K, Okudaira H, Akiyama K. p38 mitogen-activated protein kinase regulates human T cell IL-5 synthesis. J Immunol 1999;163:4763-71.
49. Rafiq K, Bullens DM, Kasran A, Lorre K, Ceuppens JL, Van Gool SW. Differences in regulatory pathways identify subgroups of T cell-derived Th2 cytokines. Clin Exp Immunol 2000;121:86-93.
50. Warren HS, Kinnear BF, Phillips JH, Lanier LL. Production of IL-5 by human NK cells and regulation of IL-5 secretion by IL-4, IL-10, and IL-12. J Immunol 1995;154:5144-52.
51. Clutterbuck EJ, Hirst EM, Sanderson CJ. Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6 and GMCSF. Blood 1989;73:1504-12.
52. Yamaguchi Y, Suda T, Ohta S, Tominaga K, Miura Y, Kasahara T. Analysis of the survival of mature human eosinopbils: interleukin-5 prevents apoptosis in mature human eosinopbils. Blood 1991;78:2542-7.
53. Limaye AP, Ottesen EA, Kumaraswami V, et al. Kinetics of serum and cellular interleukin-5 in posttreatment eosinophilia of patients with lymphatic filariasis. J Infect Dis 1993; 167:1396-400.
54. Perkerson JM, Isakson PC. Interleukin 5 (IL-5) provides a signal that is required in addition to IL-4 for isotype switching to immunoglobulin (Ig) G1 and IgE. J Exp Med 1992;175:973-82.
55. Hari Y, Urwyler A, Hurni M. et al. Distinct serum cytokine levels in drug- and measles-induced exanthema. Int Arch Allergy Immunol 1999;120:225-9.
56. Brooker S, Rowlands M, Haller L, Savioli L, Bundy DAP. Towards an atlas of human helminth infection in sub-Saharan Africa: the use of geographical information systems (GIS). Parasitol Today 2000;16:303-7.
57. Pretolani M, Goldman M. IL-10: a potential therapy for allergic inflammation? Immunol Today 1997;18:277-80.
58. Akdis CA, Blaser J. Mechanisms of interleukin-10-mediated immune suppression. Immunology 2001;103:131-6.
59. Takanaski S, Nonaka R, Xing Z, O'Byrne P, Dolovich J, Jordana M. Interleukin 10 inhibits lipopolysaccharide-induced survival and cytokine production by human peripheral blood eosinophils. J Exp Med 1994;180:711-5.
60. Schandene L, Alonso-Vega C, Willems F, et al. B7/CD28-dependent IL-5 production by human resting T cells in inhibited by IL-10. J Immunol 1994;152:4368-74.
61. Joss A, Akdis M, Faith A, Blaser K, Akdis CA. IL-10 directly acts on T cells by specifically altering the CD28 co-stimulation pathway. Eur J Immunol 2000;30:1683-90.
62. Staples KJ, Bergmann M, Barnes PJ, Newton R. Stimulus-specific inhibition of IL-5 by cAMP-elevating agents and IL-10 reveals differential mechanisms of action. Biochem Biophys Res Commun 2000;14:811-5.
63. + T lymphocyte and eosinophil infiltration into the mouse peritoneal cavity. J Immunol 1996; 157:377-84.
64. Yang X, Wang S, Fan Y, Han X. IL-10 deficiency prevents IL-5 overproduction and eosinophilic inflammation in a murine model of asthma-like reaction. Eur J Immunol 2000;30:382-91.
65. Punnonen J, de Waal Malefyt R, van Vlasselaer P, Gauchat JF, de Vries JE. IL-10 and viral IL-10 prevent IL-4-induced IgE synthesis by inhibiting the accessory cell function of monocytes. J Immunol 1993;151:1280-9.
66. Uejima Y, Takahashi K, Komoriya K, Kurozumi S, Ochs HD. Effect of interleukin-10 on anti-CD40- and interleukin-4-induced IgE production by human lymphocytes. Int Arch Allergy Immunol 1996; 110:225-32.
67. Jeannin P, Lecoanet S, Delneste Y, Gauchat JF, Bonnefoy JY. IgE versus IgG4 production can be differentially regulated by IL-10. J Immunol 1998;160:3555-61.
68. van den Biggelaar AHJ, van Ree R, Rodrigues LC, et al. Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10. Lancet 2000; 356:1723-7.
69. Yazdanbakhsh M, van den Biggelaar A, Maizels RM. Th2 responses without atopy: immunoregulation in chronic helminth infections and reduced allergic disease. Trends Immunol 2001; 22:372-7.
70. Panuska JR, Merolla R, Rebert NA, et al. Respiratory syncytial virus induces interleukin-10 by human alveolar macrophages. Suppression of early cytokine production and implications for incomplete immunity. J Clin Invest 1995; 96:2445-53.
71. Sieg S, King C, Huang Y, Kaplan D. The role of interleukin-10 in the inhibition of T-cell proliferation and apoptosis mediated by parainfluenza virus type 3. J Virol 1996; 70:4845-8.
72. Schols D, De Clercq E. Human immunodeficiency virus type 1 gp120 induces anergy in human peripheral blood lymphocytes by inducing interleukin-10 production. J Virol 1996;70:4953-60.
73. Opal SM, Wherry JC, Grint P. Interleukin-10: potential benefits and possible risks in clinical infectious diseases. Clin Infect Dis 1998;27:1497-507.
74. Barcova M, Kacani L, Speth C, Dierich MP. gp41 envelope protein of human immunodeficiency virus induces interleukin (IL)-10 in monocytes, but not in B, T, or NK cells, leading to reduced IL-2 and interferon-γ production. J Infect Dis 1998;177:905-13.
75. Stockl J, Vetr H, Majdic O, Zlabinger G, Kuechler E, Knapp W. Human major group rhinoviruses downmodulate the accessory function of monocytes by inducing IL-10. J Clin Invest 1999; 104:957-65.
76. Redpath S, Angulo A, Gascioigne NRJ, Ghazal P. Murine cytomegalovirus infection down-regulates MHC class II expression on macrophages by induction of IL-10. J Immunol 1999;162:6701-7.
77. Cacciarelli TV, Martinez OM, Gish RG, Villanueva JC, Krams SM. Immunoregulatory cytokines in chronic hepatitis C virus infection: pre- and posttreatment with interferon alfa. Hepatology 1996;24:6-9.
78. Akaboshi I, Nagayoshi I, Omura M, Iwaki K. Elevated serum levels of interleukin-10 in children with acute rubella infection. Scand J Infect Dis 2001;33:462-5.
79. Kaiser L, Fritz RS, Straus SE, Gubareva L, Hayden FG. Symptom pathogenesis during acute influenza: interleukin-6 and other cytokine responses. J Med Virol 2001;64:262-8.
80. Okada H, Sato TA, Katayama A, et al. Comparative analysis of host responses related to immunosuppression between measles patients and vaccine recipients with live attenuated measles vaccines. Arch Virol 2001;146:859-74.
81. Atabani SF, Byrnes AA, Jaye A, et al. Natural measles causes prolonged suppression of interleukin-12 production. J Infect Dis 2001;184:1-9.
82. Levy Y, Brouet JC. Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein. J Clin Invest 1994;93:424-8.
83. de Waal Malefyt R, Haanen J, Spits H, et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 1991;174:915-24.
84. - T cell clones and resting T cells. J Immunol 1993;150:4754-65.
85. Chernoff AE, Granowitz EV, Shapiro L, et al. A randomized, controlled trial of IL-10 in humans: inhibition of inflammatory cytokine production and immune responses. J Immunol 1995; 154:5492-9.
86. Stadecker MJ, Villanueva POF. Accessory cell signals regulate Th-cell responses: from basic immunology to a model of helminthic disease. Immunol Today 1994;15:571-4.
87. + T cell immunity to gag in HIV-1-infected individuals with differential disease progression: reciprocal inter-feron-γ and interleukin-10 responses. J Infect Dis 2001;184:1268-78.
88. Hsu DH, de Waal Malefyt R, Fiorentino DF, et al. Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1. Science 1990;250:830-2.
89. Kotenko SV, Saccani S, Izotova LS, Mirochnitchenko OV, Pestka S. Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proc Natl Acad Sci USA 2000;97:1695-700.
90. Rivas JM, Ullrich SE. Systemic suppression of delayed-type hypersensitivity by supernatants from UV-irradiated keratinocytes. An essential role for keratinocyte-derived IL-10. J Immunol 1992; 149:3865-71.
91. Powrie F, Menon S, Coffman RL. Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo. Eur J Immunol 1993;23:3043-9.
92. Taga K, Tosato G. IL-10 inhibits human T cell proliferation and IL-2 production. J Immunol 1992;148:1143-8.
93. Taga K, Mostowski H, Tosato G. Human interleukin-10 can directly inhibit T-cell growth. Blood 1993;81:2964-71.
94. Oswald IP, Gazzinelli RT, Sher A, James SL. IL-10 synergizes with IL-4 and transforming growth factor-β to inhibit macrophage cytotoxic activity. J Immunol 1992;148:3578-82.
95. van der Poll T, Marchant A, Keogh CV, Goldman M, Lowry SF. Interleukin-10 impairs host defense in murine pneumococcal pneumonia. J Infect Dis 1996;174:994-1000.
96. Steinhauser ML, Hogaboam CM, Kunkel SL, Lukacs NW, Strieter RM, Standiford TJ. IL-10 is a major mediator of sepsis-induced impairment in lung antibacterial host defense. J Immunol 1999; 162:392-9.
97. Redpath S, Ghazal P, Gascoigne NRJ. Hijacking and exploitation of IL-10 by intracellular pathogens. Trends Microbiol 2001;9:86-92.